FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant Read more
Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers Read more
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference Read more
Book to attend the Parallel Trade conference before midnight Friday 28 th January and save £100 Read more
FDA Approves Veklury (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression Read more
FDA Approves Second Indication for SKYRIZI (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis Read more
MustGrow and Bayer sign Exclusive Agreement to Develop Sustainable Organic Biologicals in Europe, Asia Pacific, Middle East and Africa Read more
Colorcon Ventures Invests in Intelligent Pharma Manufacturing System Provider Apprentice.io Read more
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-868 for the Treatment of Advanced Solid Tumors Read more
Senhwa’s Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer Read more